» Articles » PMID: 37457921

Change in Circulating Klotho in Response to Weight Loss, with and Without Exercise, in Adults with Overweight or Obesity

Overview
Journal Front Aging
Specialty Geriatrics
Date 2023 Jul 17
PMID 37457921
Authors
Affiliations
Soon will be listed here.
Abstract

Klotho is a protein associated with protection from aging-related diseases and health conditions. Obesity is associated with lower Klotho concentrations. Thus, this secondary analysis of adults with obesity examined 1) the change in serum Klotho concentration in response to a behavioral weight loss intervention by the magnitude of weight loss achieved; and 2) the association among serum Klotho concentration and weight, body composition, and cardiorespiratory fitness. Participants were randomized to either diet alone (DIET), diet plus 150 min of physical activity per week (DIET + PA150), or diet plus 250 min of physical activity per week (DIET + PA250). Participants [ = 152; age: 45.0 ± 7.9 years; body mass index (BMI): 32.4 ± 3.8 kg/m] included in this secondary analysis provided blood samples at baseline, 6-, and 12 months, and were classified by weight loss response (Responder: achieved ≥10% weight loss at 6 or 12 months; Non-responder: achieved <5% weight loss at both 6 and 12 months). Serum Klotho was measured using a solid-phase sandwich enzyme-linked immunosorbent assay (ELISA). Analyses of covariance (ANCOVA's) were used to examine changes in weight, body composition, cardiorespiratory fitness, and Klotho concentration by weight loss response across the 12-month weight loss intervention. Responders had a greater reduction in measures of weight and body composition, and a greater increase in cardiorespiratory fitness, compared to Non-Responders ( < 0.05). Change in Klotho concentration differed between Responders and Non-Responders ( < 0.05), with the increase in Klotho concentration from baseline to 6 months for Responders being statistically significant. The 6-month change in Klotho concentration was inversely associated with the 6-month change in weight ( = -0.195), BMI ( = -0.196), fat mass ( = -0.184), and waist circumference ( = -0.218) (-values <0.05). Findings provide evidence within the context of a behavioral intervention, with and without exercise, that change in Klotho concentration is significantly different between adults with weight loss ≥10% compared to <5% across 12 months. These findings suggest that weight loss and reduction in fat mass may be favorably associated with the change in Klotho concentration. This may reduce the risk of negative health consequences associated with accelerated aging in middle-aged adults.

Citing Articles

Influence of Klotho Protein Levels in Obesity and Sarcopenia: A Systematic Review.

Ariadel-Cobo D, Estebanez B, Gonzalez-Arnaiz E, Garcia-Perez M, Rivera-Viloria M, Pintor de la Maza B Int J Mol Sci. 2025; 26(5).

PMID: 40076542 PMC: 11900336. DOI: 10.3390/ijms26051915.


Metabolically healthy across body mass index categories in relation to serum Klotho levels: a population-based study.

Shu Y, Yang J, Dou L, Wu M Front Endocrinol (Lausanne). 2025; 16:1539983.

PMID: 40060377 PMC: 11885134. DOI: 10.3389/fendo.2025.1539983.


Correlation of the weight-adjusted waist circumference index with Klotho in the United States: differences by sex.

Yin H, Qiu Y, Guo L, Zhu W, Li W, Zhou Y Sci Rep. 2024; 14(1):31118.

PMID: 39732752 PMC: 11682226. DOI: 10.1038/s41598-024-82388-6.


Association between weight change and serum anti-aging protein α-Klotho: a cross-sectional study in middle-aged and older adults.

Chen S, Kong Y, Wang N, Kang N, Chen H, Zhang Z Sci Rep. 2024; 14(1):18624.

PMID: 39128946 PMC: 11317480. DOI: 10.1038/s41598-024-69556-4.


Association between plasma trans fatty acids and serum α-klotho levels in adults in the United States of America: an analysis of the NHANES 2009-2010 datasets.

Liang Y, Zhu Y, Zhang M, Zhang Y, Jiang S, Wang X Lipids Health Dis. 2024; 23(1):241.

PMID: 39118087 PMC: 11308666. DOI: 10.1186/s12944-024-02226-6.

References
1.
Flegal K, Carroll M, Kit B, Ogden C . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307(5):491-7. DOI: 10.1001/jama.2012.39. View

2.
Razzaque M . The role of Klotho in energy metabolism. Nat Rev Endocrinol. 2012; 8(10):579-87. PMC: 3704949. DOI: 10.1038/nrendo.2012.75. View

3.
Tsujinaka S, Konishi F, Kawamura Y, Saito M, Tajima N, Tanaka O . Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum. 2008; 51(12):1757-65. DOI: 10.1007/s10350-008-9395-0. View

4.
Socha-Banasiak A, Michalak A, Paczes K, Gaj Z, Fendler W, Socha A . Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters. BMC Pediatr. 2020; 20(1):294. PMC: 7296965. DOI: 10.1186/s12887-020-02199-2. View

5.
Chen Y, Dabbas W, Gangemi A, Benedetti E, Lash J, Finn P . Obesity Management and Chronic Kidney Disease. Semin Nephrol. 2021; 41(4):392-402. DOI: 10.1016/j.semnephrol.2021.06.010. View